We are live on ! Find out more
YIH

Y-Intercept (HK) Portfolio holdings

AUM $5.05B
1-Year Est. Return 17.89%
This Fund
S&P 500
This Quarter Est. Return
+8.69%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
AUM
$393M
AUM Growth
+$20.1M
Cap. Flow
+$9.32M
Cap. Flow %
2.37%
Top 10 Hldgs %
14.62%
Holding
983
New
387
Increased
109
Reduced
91
Closed
395

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$12.3M
2
MRNA icon
Moderna
MRNA
+$5.95M
3
QCOM icon
Qualcomm
QCOM
+$4.24M
4
TAL icon
TAL Education Group
TAL
+$3.82M
5
AMD icon
Advanced Micro Devices
AMD
+$3.65M

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$3.44M
2
KMB icon
Kimberly-Clark
KMB
+$2.7M
3
MCO icon
Moody's
MCO
+$2.68M
4
UPS icon
United Parcel Service
UPS
+$2.64M
5
SHW icon
Sherwin-Williams
SHW
+$2.59M

Sector Composition

Rank Sector Weight
1 Healthcare 17.91%
2 Technology 17.83%
3 Consumer Discretionary 11.15%
4 Industrials 9.32%
5 Materials 8.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MUSA icon
801
Murphy USA
MUSA
$11.4B
-6,044
Closed -$912K
NEO icon
802
NeoGenomics
NEO
$1.74B
-6,905
Closed -$309K
NGG icon
803
National Grid
NGG
$81.8B
-6,394
Closed -$334K
NI icon
804
NiSource
NI
$22B
-27,573
Closed -$661K
NICE icon
805
Nice
NICE
$5.55B
-5,574
Closed -$1.21M
NIU
806
Niu Technologies
NIU
$208M
-8,208
Closed -$289K
NLY icon
807
Annaly Capital Management
NLY
$17B
-7,745
Closed -$270K
NOBL icon
808
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.8B
-16,804
Closed -$728K
NOVT icon
809
Novanta
NOVT
$5.02B
-1,913
Closed -$247K
NVCR icon
810
NovoCure
NVCR
$2.01B
-6,239
Closed -$781K
NVO
811
Novo Nordisk
NVO
$219B
-18,478
Closed -$628K
NVR icon
812
NVR
NVR
$17.2B
-51
Closed -$240K
O icon
813
Realty Income
O
$61.3B
-19,930
Closed -$1.24M
OI icon
814
O-I Glass
OI
$1.43B
-11,346
Closed -$165K
ORA icon
815
Ormat Technologies
ORA
$6.16B
-12,682
Closed -$965K
ORLY icon
816
O'Reilly Automotive
ORLY
$75.2B
-27,015
Closed -$917K
OTIS icon
817
Otis Worldwide
OTIS
$28B
-22,023
Closed -$1.54M
PACB icon
818
Pacific Biosciences
PACB
$422M
-17,256
Closed -$517K
PAGS icon
819
PagSeguro Digital
PAGS
$2.62B
-17,478
Closed -$797K
PARA
820
DELISTED
Paramount Global Class B
PARA
-37,901
Closed -$1.77M
PBI icon
821
Pitney Bowes
PBI
$2.47B
-11,150
Closed -$90K
PBR icon
822
Petrobras
PBR
$117B
-53,994
Closed -$440K
PBW icon
823
Invesco WilderHill Clean Energy ETF
PBW
$402M
-5,414
Closed -$510K
PCG icon
824
PG&E
PCG
$47.3B
-39,324
Closed -$452K
PCTY icon
825
Paylocity
PCTY
$7.12B
-1,291
Closed -$220K

Similar funds

Y-Intercept (HK)'s Q2 2021 Portfolio in Review

As of Q2 2021, Y-Intercept (HK) held 983 positions worth $393M, up 5.4% from $373M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Y-Intercept (HK)'s Q2 2021 filing shows 387 new, 109 increased, 91 reduced and 395 closed positions. Its largest new stake was Linde: 42,339 shares worth $12.2M. The largest sale was Baidu, an estimated $3.44M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Y-Intercept (HK)'s largest Q2 2021 buy was Linde: 42,339 shares worth $12.2M.
  • Y-Intercept (HK) added most to Moderna in Q2 2021, an estimated $5.95M increase.
  • Y-Intercept (HK)'s biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $2.59M.
  • Y-Intercept (HK) fully exited Baidu in Q2 2021, selling an estimated $3.44M.
  • Y-Intercept (HK)'s ten largest holdings make up 15% of its $393M portfolio in Q2 2021.
  • Y-Intercept (HK) opened 387 new positions and closed 395 in Q2 2021.
  • Y-Intercept (HK)'s portfolio value rose 5.4% quarter-over-quarter to $393M.

Based on Y-Intercept (HK)'s 13F filing for Q2 2021, filed 12 Aug 2021.